Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

Two-Year Outcomes of Valoctocogene Roxaparvovec Therapy for Hemophilia A.

Journal article

Mahlangu J. et al, (2023), N Engl J Med, 388, 694 - 705

Phase 1-2 Trial of AAVS3 Gene Therapy in Patients with Hemophilia B.

Journal article

Chowdary P. et al, (2022), N Engl J Med, 387, 237 - 247

The suboptimal fibrinolytic response in COVID-19 is dictated by high PAI-1.

Journal article

Whyte CS. et al, (2022), J Thromb Haemost

Illustrated State-of-the-Art Capsules of the ISTH 2022 Congress.

Journal article

Ariëns RA. et al, (2022), Res Pract Thromb Haemost, 6

The bleeding phenotype in people with non-severe hemophilia.

Journal article

Kloosterman FR. et al, (2022), Blood Adv

Cardiovascular disease in hereditary haemophilia: The challenges of longevity.

Journal article

Shapiro S. et al, (2022), Br J Haematol

Message in a platelet: decoding platelet transcriptomes in myeloproliferative neoplasms.

Journal article

Shapiro S. et al, (2021), Cell Rep Med, 2

Experience of Covid 19 vaccination in patients with bleeding disorders.

Journal article

Peck RC. et al, (2021), Haemophilia

Acquired haemophilia A diagnosed during pregnancy

Journal article

Ejaz A. et al, (2021), Obstetric Medicine

Load More